A Peek At How Janssen’s Supply Chain Withstood COVID-19 Disruptions

Exec Outlines Preparedness To Distribute COVID-19 Vaccine

A senior executive of Janssen’s supply chain leadership team outlines how the company handled activities in Asia Pacific at the height of the coronavirus outbreak, including ensuring continuous and rapid supplies of critical medicines in China. The company is also prepping against “multiple scenarios” to ensure global access for its potential COVID-19 vaccine.

Chris Ewer VP
Chris Ewer, Vice President, Janssen Supply Chain (Asia Pacific) • Source: J&J

If supply chain and logistics teams in pharma were traditionally seen as behind-the-scenes operations types, then the coronavirus pandemic has changed that dramatically, putting these functions front and center.

As global supply chain networks tottered during the early days of COVID-19, senior executives had to juggle multiple priorities while...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip